American Century Companies’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-451
Closed -$113K 1306
2018
Q3
$113K Sell
451
-1,288
-74% -$323K ﹤0.01% 1248
2018
Q2
$776K Buy
+1,739
New +$776K ﹤0.01% 1135